Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2360

1.

Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat.

Nutan, Modi M, Dezzutti CS, Kulshreshtha S, Rawat AK, Srivastava SK, Malhotra S, Verma A, Ranga U, Gupta SK.

Virol J. 2013 Oct 18;10:309. doi: 10.1186/1743-422X-10-309.

2.

Transcriptome analysis of primary monocytes from HIV-positive patients with differential responses to antiretroviral therapy.

Wu JQ, Sassé TR, Saksena MM, Saksena NK.

Virol J. 2013 Dec 27;10:361. doi: 10.1186/1743-422X-10-361.

3.

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.

Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, Lalone D, Glaser J, Loughran T, Sheremata W, Poiesz BJ.

Virol J. 2013 Dec 23;10:360. doi: 10.1186/1743-422X-10-360.

4.
5.

Roles and functions of HIV-1 Tat protein in the CNS: an overview.

Bagashev A, Sawaya BE.

Virol J. 2013 Dec 21;10:358. doi: 10.1186/1743-422X-10-358. Review.

6.

Local production of CCL3, CCL11, and IFN-γ correlates with disease severity in murine parainfluenza virus infection.

Suryadevara M, Bonville CA, Rosenberg HF, Domachowske JB.

Virol J. 2013 Dec 21;10:357. doi: 10.1186/1743-422X-10-357.

7.

Comprehensive analysis of the overall codon usage patterns in equine infectious anemia virus.

Yin X, Lin Y, Cai W, Wei P, Wang X.

Virol J. 2013 Dec 20;10:356. doi: 10.1186/1743-422X-10-356.

8.

Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients.

Paolucci S, Fiorina L, Mariani B, Gulminetti R, Novati S, Barbarini G, Bruno R, Baldanti F.

Virol J. 2013 Dec 17;10:355. doi: 10.1186/1743-422X-10-355.

9.

Characterization of an envelope gene VP19 from Singapore grouper iridovirus.

Huang X, Gong J, Huang Y, Ouyang Z, Wang S, Chen X, Qin Q.

Virol J. 2013 Dec 16;10:354. doi: 10.1186/1743-422X-10-354.

10.

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW.

Virol J. 2013 Dec 13;10:353. doi: 10.1186/1743-422X-10-353.

11.

Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani population.

Mansoor A, Ali L, Sabah NU, Hashmi AH, Khan MH, Kazmi SA, Ahmad N, Siddiqi S, Khan KM.

Virol J. 2013 Dec 9;10:352. doi: 10.1186/1743-422X-10-352.

12.

Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan.

Anwar MI, Rahman M, Hassan MU, Iqbal M.

Virol J. 2013 Dec 5;10:351. doi: 10.1186/1743-422X-10-351.

13.

Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy.

Noguera-Julian M, Casadellà M, Pou C, Rodríguez C, Pérez-Álvarez S, Puig J, Clotet B, Paredes R.

Virol J. 2013 Dec 5;10:350. doi: 10.1186/1743-422X-10-350.

14.

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.

Warimwe GM, Lorenzo G, Lopez-Gil E, Reyes-Sandoval A, Cottingham MG, Spencer AJ, Collins KA, Dicks MD, Milicic A, Lall A, Furze J, Turner AV, Hill AV, Brun A, Gilbert SC.

Virol J. 2013 Dec 5;10:349. doi: 10.1186/1743-422X-10-349.

15.

Molecular investigation of the 7.2 kb RNA of murine cytomegalovirus.

Schwarz TM, Volpe LA, Abraham CG, Kulesza CA.

Virol J. 2013 Dec 2;10:348. doi: 10.1186/1743-422X-10-348.

16.

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models.

Lacerda M, Moore PL, Ngandu NK, Seaman M, Gray ES, Murrell B, Krishnamoorthy M, Nonyane M, Madiga M, Wibmer CK, Sheward D, Bailer RT, Gao H, Greene KM, Karim SS, Mascola JR, Korber BT, Montefiori DC, Morris L, Williamson C, Seoighe C; CAVD-NSDP Consortium.

Virol J. 2013 Dec 2;10:347. doi: 10.1186/1743-422X-10-347.

17.

Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+.

Pawełczyk A, Kubisa N, Jabłońska J, Bukowska-Ośko I, Caraballo Cortes K, Fic M, Laskus T, Radkowski M.

Virol J. 2013 Nov 26;10:346. doi: 10.1186/1743-422X-10-346.

18.

Genetic mutations in influenza H3N2 viruses from a 2012 epidemic in Southern China.

Zhong J, Liang L, Huang P, Zhu X, Zou L, Yu S, Zhang X, Zhang Y, Ni H, Yan J.

Virol J. 2013 Nov 26;10:345. doi: 10.1186/1743-422X-10-345.

19.

Infectious salmon anaemia virus (ISAV) in Chilean Atlantic salmon (Salmo salar) aquaculture: emergence of low pathogenic ISAV-HPR0 and re-emergence of virulent ISAV-HPR∆: HPR3 and HPR14.

Godoy MG, Kibenge MJ, Suarez R, Lazo E, Heisinger A, Aguinaga J, Bravo D, Mendoza J, Llegues KO, Avendaño-Herrera R, Vera C, Mardones F, Kibenge FS.

Virol J. 2013 Nov 23;10:344. doi: 10.1186/1743-422X-10-344.

20.

Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.

Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, Gagneux P.

Virol J. 2013 Nov 22;10:321. doi: 10.1186/1743-422X-10-321.

Supplemental Content

Loading ...
Support Center